EZH2 and neoplasm: In contrast, Mo-TAMs triggered a similar tumor cell proliferation rate in both DMSO and EPZ-6438-treated MCS, indicating that their tumor-promoting effects had abolished the antiproliferative activity of EZH2 inhibition.